Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29044971
Publication Date : 2017/10/18

Drug nanocrystals for cancer therapy.


Drug nanocrystals (NCs) with fascinating physicochemical properties have attracted great attention in drug delivery. High drug-loading efficiency, great structural stability, steady dissolution, and long circulation time are a few examples of these properties, which makes drug NCs an excellent formulation for efficient cancer therapy. In the last two decades, there are a lot of hydrophobic or lipophilic drugs, such as paclitaxel (PTX), camptothecin (CPT), thymectacin, busulfan, cyclosporin A, 2-devinyl-2-(1-hexyloxyethyl) pyropheophorbide (HPPH), and so on, which have been formulated into drug NCs for cancer therapy. In this review, we summarized the recent advances in drug NCs-based cancer treatment. So far, there are main three methods to synthesize drug NCs, including top-down, bottom-up, and combination methods. The characterization methods of drug NCs were also elaborated. Furthermore, the applications and mechanisms of drug NCs were introduced by their administration routes. At the end, we gave a brief conclusion and discussed the future perspectives of drug NCs in cancer therapy. For further resources related to this article, please visit the WIREs website.

Authors : Miao Xiaoqing , Yang Wuwei , Feng Tao , Lin Jing , Huang Peng ,

Related products :

Catalog number Product name Quantity
orb61244 Erlotinib Erlotinib hydrochloride is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. For research use only. 100 mg
27-424 Altered expression of GBX2, part of the homeobox-containing human family of DNA-binding transcription factors, is associated with therapy failure and death in patients with multiple types of cancer. 0.1 mg
0940106 Magnetic Iron Oxide Nanocrystals Powder 20mg
orb61248 GDC-0449 Vismodegib is an investigational drug for the treatment of various types of cancer. For research use only. 50 mg
orb61205 ABT-888 Veliparib (ABT-888) is a potential anti-cancer drug acting as a PARP inhibitor.It inhibits both PARP1 and PARP2. For research use only. 10 mg
orb61255 INCB018424 Ruxolitinib is a drug being investigated for the treatment of myeloproliferative diseases, plaque psoriasis, and various types of cancer. For research use only. 5 mg
orb61271 NVP-AUY922 NVP-AUY922 is an experimental drug candidate for the treatment of cancer. For research use only. 5 mg
orb61251 Gefitinib Gefitinib is a drug used in the treatment of certain types of cancer. For research use only. 100 mg
orb61351 Oxaliplatin Oxaliplatin is a a third-generation, diaminocyclohexane-containing platinum anti-cancer drug. For research use only. 500 mg
orb61241 Doxorubicin Doxorubicin is a drug used in cancer chemotherapy. For research use only. 100 mg
orb60355 Amonafide Amonafide is a drug used in the treatment of cancer. For research use only. 5 mg
orb61254 Imatinib (free base) Imatinib (originally STI571) is a drug used to treat certain types of cancer. For research use only. 100 mg
orb60727 Flutamide Flutamide(Eulexin) is an oral nonsteroidal antiandrogen drug primarily used to treat prostate cancer. For research use only. 10 mg
SENSIVUESECONDARY Drug susceptibility (secondary anti_tubercular drug) test for M.tuberculosis with a nitrate reductase assay using proportion method. One Set
SENSIVUEPRIMARY Drug susceptibility (primary anti_tubercular drug) test for M.tuberculosis with a nitrate reductase assay using proportion method. One Set
orb61256 Lapatinib (free base) Lapatinib, used in the form of lapatinib ditosylate, (USAN) (Tykerb_Tyverb, GSK) is an orally active drug for breast cancer and other solid tumours. For research use only. 100 mg
B437 Brain Heart Infusion w_PABA USE : For examination of blood from patients under sulphonamide therapy. 5x500gm
B437 Brain Heart Infusion w_PABA USE For examination of blood from patients under sulphonamide therapy. Qty per Litre of Medium: 37
orb61230 Canertinib Canertinib (CI-1033) is an experimental drug candidate for the treatment of cancer. It is an irreversible tyrosine-kinase inhibitor with activity against EGFR (IC50 0.8 nM), HER-2 (IC50 19 500 mg
orb60291 Artemisinin Artemisinin is a drug used to treat multi-drug resistant strains of falciparum malaria. For research use only. 200 mg
orb60556 Prednisone Prednisone(Adasone) is a synthetic corticosteroid drug that is particularly effective as an immunosuppressant drug. For research use only. 25 mg
orb61257 Lapatinib (ditosylate salt) Lapatinib, used in the form of lapatinib ditosylate, (USAN) (Tykerb_Tyverb, GSK) is an orally active drug for breast cancer and other solid tumours. For research use only. 100 mg
orb60678 Verteporfin Verteporfin(Visudyne), a benzoporphyrin derivative, is a medication used as a photosensitizer for photodynamic therapy. For research use only. 10 mg
28-896 The t (16;21) (q24;q22) translocation is a rare but recurrent chromosomal abnormality associated with therapy-related myeloid malignancies. The translocation produces a chimeric gene made up of the 5' 0.1 mg
27-985 The t (16;21) (q24;q22) translocation is a rare but recurrent chromosomal abnormality associated with therapy-related myeloid malignancies. The translocation produces a chimeric gene made up of the 5' 0.05 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur